News | Lumen Bioscience

9/1/2020	Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs
7/23/2020	Lumen Wins Triple Funding Boost to Advance Development of Low-Cost Therapeutics for Newborns and Infants in Developing Countries
7/23/2020	Dr. Craig Behnke Joins Lumen Bioscience as SVP, Production and Development
7/23/2020	Lumen Bioscience Announces Issuance of US Patent for Genetic Modification of Spirulina
7/8/2020	NIH Awards Grant to Lumen Bioscience for Cost-Effective Oral Malaria Vaccine
4/1/2020	Lumen Wins Grant to Develop Ultra-Low-Cost Therapeutics for Treating Infant Diseases in Developing Countries